OTS167 alone or in combination with tyrosine kinase inhibitors were used to investigate the effect of OTS167 on FLT3 signaling and expression in human Fms-like tyrosine kinase 3 (FLT3) mutant acute myeloid leukemia cell lines and primary cells.
[Blood Cancer Journal]
6445212 4NESHC98 items 1 apa default asc 1
Eisfelder, B. J., Saygin, C., Wynne, J., Colton, M. W., Fischietti, M., Beauchamp, E. M., Cheng, J. X., Odenike, O., Roboz, G., Alachkar, H., & Stock, W. (2021). OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia. Blood Cancer Journal, 11(3), 1–15. https://doi.org/10.1038/s41408-021-00433-3 Cite
Cisplatin and anti-CD133 chimeric antigen receptor T (CAR-T) combination treatment inhibited tumor progression in three different xenograft models with diminished CD133 positive stem cell-like cell infiltration.
[Cancer Immunology Immunotherapy]
Using tissue microarray sections, immunohistochemistry was performed on 360 PTs. Epithelial and stromal expressions of EZH2, EZR, HMGA2, CD24 and CD44 were evaluated to assess their impact on disease progression and behavior in correlation with clinicopathological parameters.
[Cancer Cell International]
6445212 IG93H443 items 1 apa default asc 1
Ahmed, S. S., Lim, J. C. T., Thike, A. A., Iqbal, J., & Tan, P. H. (2021). Epithelial–mesenchymal transition and cancer stem cell interactions in breast phyllodes tumours: immunohistochemical evaluation of EZH2, EZR, HMGA2, CD24 and CD44 in correlation with outcome analysis. Journal of Clinical Pathology. https://doi.org/10.1136/jclinpath-2020-207068 Cite
Investigators found that bortezomib (bort) suppressed cell proliferation and decreased colony formation in human and murine leukemic blasts. Bort reduced the frequency and function of leukemia stem cells, inhibited the progression, and extended the overall survival in mixed‐lineage leukemia‐AF9‐transformed leukemic mice.
[Journal of Cellular and Molecular Medicine]
6445212 9GUCT8SL items 1 apa default asc 1
Zhou, B., Qin, Y., Zhou, J., Ruan, J., Xiong, F., Dong, J., Huang, X., Yu, Z., & Gao, S. (n.d.). Bortezomib suppresses self-renewal and leukemogenesis of leukemia stem cell by NF-ĸB-dependent inhibition of CDK6 in MLL-rearranged myeloid leukemia. Journal of Cellular and Molecular Medicine, n/a(n/a). https://doi.org/https://doi.org/10.1111/jcmm.16377 Cite
The National Marrow Donor Program®/Be The Match® announced plans to launch the ACCESS clinical trial titled “A Multicenter Phase II Trial of HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Patients with Hematologic Malignancies.”
[The National Marrow Donor Program®]
6445212 nan items 1 apa default asc 1
Researchers demonstrated that leukemia stem cells, hematopoietic stem cells, and pre-leukemic stem cells could be identified and molecularly profiled by combining single-cell transcriptomics with lineage tracing using both nuclear and mitochondrial somatic variants.
6445212 VJYMY43V items 1 apa default asc 1
Velten, L., Story, B. A., Hernández-Malmierca, P., Raffel, S., Leonce, D. R., Milbank, J., Paulsen, M., Demir, A., Szu-Tu, C., Frömel, R., Lutz, C., Nowak, D., Jann, J.-C., Pabst, C., Boch, T., Hofmann, W.-K., Müller-Tidow, C., Trumpp, A., Haas, S., & Steinmetz, L. M. (2021). Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomics. Nature Communications, 12(1), 1366. https://doi.org/10.1038/s41467-021-21650-1 Cite
Investigators investigated the interplay and networking pathways occurring between TGFβ family ligands in regulating stemness in triple negative breast cancer (TNBC). They found that TGFβ stimulation of TNBCs resulted in enhanced tumorsphere formation efficiency and an increased proportion of the highly tumorigenic CD44high/CD24low cancer stem cell population.
6445212 MYWEYDI2 items 1 apa default asc 1
The authors found that IL-17RB expression was significantly upregulated in spheroid cells and Lgr5-positive cells from the same tumor tissues of patients with gastric cancer, which was closely correlated with the degree of cancer cell differentiation.
6445212 3Q93YQ79 items 1 apa default asc 1
Bie, Q., Song, H., Chen, X., Yang, X., Shi, S., Zhang, L., Zhao, R., Wei, L., Zhang, B., Xiong, H., & Zhang, B. (2021). IL-17B/IL-17RB signaling cascade contributes to self-renewal and tumorigenesis of cancer stem cells by regulating Beclin-1 ubiquitination. Oncogene, 1–17. https://doi.org/10.1038/s41388-021-01699-4 Cite
Researchers investigated the effects of Bruton’s tyrosine kinase (BTK) on oncurrent chemoradiotherapy-resistant oral squamous cell carcinoma tissues (OSCC). The effect of ibrutinib, a first-in-class BTK inhibitor, was tested on stem cell-like OSCC tumorspheres.
6445212 X6G8SEBA items 1 apa default asc 1
Liu, S.-C., Wu, Y.-C., Huang, C.-M., Hsieh, M.-S., Huang, T.-Y., Huang, C.-S., Hsu, T.-N., Huang, M.-S., Lee, W.-H., Yeh, C.-T., & Lin, C.-S. (2021). Inhibition of Bruton’s tyrosine kinase as a therapeutic strategy for chemoresistant oral squamous cell carcinoma and potential suppression of cancer stemness. Oncogenesis, 10(2), 1–18. https://doi.org/10.1038/s41389-021-00308-z Cite
The authors developed a 3D culture platform that mimics the metastatic tumor extracellular matrix to effectively increase cancer stem cell (CSC) population in vitro and allow CSC analysis.
6445212 6JWNEHKQ items 1 apa default asc 1
HSC-derived Mixed Lineage Leukemia- acute myeloid leukemia gene fusions was highly resistant to chemotherapy and expressed elevated amounts of the multispecific anion transporter ABCC3.
[Science Translational Medicine]
6445212 RW4CIMPU items 1 apa default asc 1
Zeisig, B. B., Fung, T. K., Zarowiecki, M., Tsai, C. T., Luo, H., Stanojevic, B., Lynn, C., Leung, A. Y. H., Zuna, J., Zaliova, M., Bornhauser, M., Bonin, M. von, Lenhard, B., Huang, S., Mufti, G. J., & So, C. W. E. (2021). Functional reconstruction of human AML reveals stem cell origin and vulnerability of treatment-resistant MLL-rearranged leukemia. Science Translational Medicine, 13(582). https://doi.org/10.1126/scitranslmed.abc4822 Cite